Tag:
OrbiMed Advisors
Latest Headlines
Latest Headlines
OrbiMed launches $600M fund for royalty, debt deals
OrbiMed, a big venture investor in the biotech industry, has assembled a $600 million fund to lure life sciences companies looking for some quick cash on royalty streams or a fresh source of debt
Ambit bounces back from dropped IPO with $30M round
A day after word that Ambit Biosciences had dropped plans for an $86 million IPO, venture investors have swooped in and replenished the cancer drug developer's coffers with a $30 million equity
SMT raises $10.5M for embolic protection device
Israeli start-up SMT Research and Development has received $10.5 million in a financing round led by OrbiMed Advisors. The start-up, which focuses on the development and commercialization of tools
